YD Bio Ltd (YDES)

• Market cap: $171M
• 1 day: -3.97%
• 5 days: -27.98%
• 1 month: -52.17%
• 3 months: -61.83%
• 6 months: -78.66%
• Year to date: -79.83%
• 1 year: -80.64%
• 5 years: -80.64%
• 10 years: -80.64%
• Sector: Healthcare
• Industry: Biotechnology

About: YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.

Employees: 15